LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/FDA Clears Novel System for When There’s No Time for Fusion
Legal & Regulatory and Reimbursement

FDA Clears Novel System for When There’s No Time for Fusion

November 20, 2020 2 min read Premium comments

Advertisement

FDA Clears Novel System for When There’s No Time for Fusion
VADER Pedicle System / Courtesy of icotec AG
#spinalfusion#pediclescrews#icotecmedical

Some patients with advanced-stage tumors don’t have enough time to wait for a successful spinal fusion. For those patients, FDA 510(k) clearance of Swiss-based icotec AG’s Vader Pedicle System and bone cements may ease their remaining days.

No Time for Fusion

The system, according to FDA documents dated October 13, 2020, is intended to “restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy, prior to oncological treatment, is of insufficient duration to permit achievement of fusion.”

VADER Pedicle System

Vader “…is a posterior pedicle system manufactured from Carbon/PEEK using a proprietary manufacturing process and consists of polyaxial pedicle screws and curved, straight and J-rods as well as polyaxial, cannulated, fenestrated pedicle screws. The system can be used for single or multiple level fixations in the non-cervical spine.”

The fenestrated pedicle screws allow for bone cement augmentation to increase stability in patients with compromised bone and are used in conjunction with the company’s G21 V-Fast or V-Steady Bone Cement and PicoMix V and/or V-HP Gun with a cement cannula, which mix and inject the bone cement. The intended use is limited at spinal levels “where the structural integrity of the spine is not severely compromised.”

Bone Cements

FDA documents state the “V-Steady and V-Fast are polymethylmethacrylate (PMMA) based bone cements formulated to perform percutaneous vertebral augmentation procedures, such as vertebroplasty or kyphoplasty. Bone cements are self-curing systems consisting of liquid and powder components.”

Advertisement

V-Steady bone cement has an “immediate development of viscosity and thus it is a high viscosity cement that maintains its properties throughout the useful working time.” The V-Fast has a “low initial viscosity and a long working time allowing to work extremely carefully especially when a good time margin before polymerization is required.”

Surgeons have options with a minimally invasive and open approach for posterior spinal surgery.

icotec AG

icotec AG, established in 1999, is family-owned in Altstaetten, Switzerland. The company designs and manufactures nonmetallic spinal implants made from BlackArmor® (Carbon/PEEK). icotec’s proprietary BlackArmor® material consists of continuous carbon fibers combined with PEEK (polyether ether ketone) and is produced using icotec’s injection molding CFM (Composite Flow Molding) manufacturing technology.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy